February 28th, 2022 - A review article in Molecular Therapy available online March 10, 2022, explores the non-immunological and immunological processes that may limit or improve durability and the strategies that can be employed to increase the duration of the therapeutic effect. The authors suggest CpG- depletion of AAV vectors as one strategy to enhance long-term transgene expression.